On May 13, 2013, TearLab Corp. (TearLab) reported its consolidated financial results for the Q1 2013. The Company reported revenues of $2.5 million, reflecting a significant increase of 486.5% YoY. The Company's net loss was approximately $8.6 million, or $0.30 per share, compared to a net loss of $9.1 million or $0.44 per share in Q1 2012. "We started 2013 with strong system orders and a solid launch of our new Masters program," said Elias Vamvakas, TearLab's Chief Executive Officer. "While our revenue growth highlights our continuing success in building a recurring revenue base, like in previous quarters, our strong sales performance was not fully reflected in our Q1-2013 financial results due to the traditional lag between access program contract signing and product shipment, and to our current system manufacturing back-order position. Moving forward, driven by the success of our sales and marketing programs, and by strong showings at key events like ASCRS, we expect to see this positive momentum continue through the year." The Full Research Report on TearLab Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at [http://www.wsreports.com/r/full_research_report/53d7_TEAR]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.